ginsenoside-rd and Acute-Kidney-Injury

Ginsenoside-Rd has been proved to decrease the severity of renal injury induced by cisplatin, in which proximal urinaferous tubules represent the main site of injury. When ginsenoside-Rd was given orally at a dose of 1 or 5 mg/kg body weight/day for 30 consecutive days prior to cisplatin injection, the activities of the antioxidation enzymes superoxide dismutase and catalase were higher, while malondialdehyde levels in serum and renal tissue were lower in the treated rats than in the controls. The levels of urea nitrogen and creatinine in serum were decreased in rats given ginsenoside-Rd. Decreased urinary levels of glucose, sodium and potassium reflected a protective action against the renal dysfunction caused by cisplatin. In addition, it was demonstrated that ginsenoside-Rd affected cultured proximal tubule cells exposed to cisplatin.

Topics: Acute Kidney Injury; Administration, Oral; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Catalase; Cells, Cultured; Cisplatin; Creatinine; Ginsenosides; Glutathione Peroxidase; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Male; Malondialdehyde; Panax; Phytotherapy; Plants, Medicinal; Rats; Rats, Wistar; Saponins; Superoxide Dismutase